Stein, Stafford v. Schering-Plough Corp.

Bailey Glasser successfully obtained a $56 million settlement in the civil portion of qui tam claims that Schering-Plough marketed drugs off-label for uses that had not been approved by the FDA.

Practice Areas

Jump to Page

Our website uses cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. By continuing to browse this website, you are agreeing to our Cookie Policy.